ADAP - Adaptimmune Therapeutics plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5442.93M
Enterprise Value 3220.96M
Trailing P/E N/A
Forward P/E 1-3.68
PEG Ratio (5 yr expected) 1-3.62
Price/Sales (ttm)7.44
Price/Book (mrq)1.79
Enterprise Value/Revenue 33.71
Enterprise Value/EBITDA 6-2.96

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018


Profit Margin -160.51%
Operating Margin (ttm)-138.42%

Management Effectiveness

Return on Assets (ttm)-18.46%
Return on Equity (ttm)-42.46%

Income Statement

Revenue (ttm)59.51M
Revenue Per Share (ttm)0.61
Quarterly Revenue Growth (yoy)-65.40%
Gross Profit (ttm)-38.76M
EBITDA -74.56M
Net Income Avi to Common (ttm)-95.51M
Diluted EPS (ttm)-0.9810
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)205.13M
Total Cash Per Share (mrq)1.96
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)9.46
Book Value Per Share (mrq)2.36

Cash Flow Statement

Operating Cash Flow (ttm)-104.39M
Levered Free Cash Flow (ttm)-86.09M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.37
52-Week Change 3-64.86%
S&P500 52-Week Change 311.15%
52 Week High 314.6250
52 Week Low 33.5500
50-Day Moving Average 34.2214
200-Day Moving Average 35.5706

Share Statistics

Avg Vol (3 month) 3258.88k
Avg Vol (10 day) 3192.93k
Shares Outstanding 5104.71M
Float 43.24M
% Held by Insiders 10.22%
% Held by Institutions 173.00%
Shares Short (Mar 29, 2019) 44.28M
Short Ratio (Mar 29, 2019) 414.77
Short % of Float (Mar 29, 2019) 4N/A
Short % of Shares Outstanding (Mar 29, 2019) 44.10%
Shares Short (prior month Feb 28, 2019) 43.83M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A